ANNOUNCEMENT

NOBEL PRIZE 2026

This year's laureates, their fields, and the discoveries that earned them the prize.Live nowSee the winners
Moonbase
← Back to Awards
NIHNATIONAL CANCER INSTITUTE

Core 2: Research Education

Active
Institution
BECKMAN RESEARCH INSTITUTE/CITY OF HOPE, CA
Principal investigator
Tijana Talisman
Funding
$146K
Duration
2023–2028
Open portfolio

Moonbase score

Still being scored

Abstract

Through a partnership between University of California, Riverside (UCR) and City of Hope Comprehensive Cancer Center (CoHCCC), we aim to develop the resources, infrastructure, and training to help 1) UCR take their scientific ideas forward to develop therapeutic agents and ultimately initiate clinical trials and 2) mentor the next generation of drug development researchers and clinical trialists. To this end, the UCR–CoHCCC Research Education Core (REC) will integrate research experiences, curriculum development, and education activities that focus on 1) drug discovery, 2) resources to translate basic science discovery to drive drug development, and 3) training ethics and HIPPA. Our goals are to develop cancer research and drug development capacity at UCR through: Aim 1: UCR–CoH Pathways to increase capacity in drug development and clinical trials. Aim 2: Curriculum to introduce both UCR and CoH students and faculty to methods and innovation in drug development. Aim 3: Outreach Education and Resources to 1) expose students, post-doctoral fellows, and early-stage investigators to career opportunities in drug development and clinical trials and 2) provide training and capacity building.

LOADING MOONBASE SCORE

NATIONAL CANCER INSTITUTEU54ZCA1-SRB-2clinical trialsdrug developmentresearch educationdrugcohcccucrriversidedevelopment clinical

Questions for BECKMAN RESEARCH INSTITUTE/CITY OF HOPE

Answered by the team behind this research.

Same institution, same topic, scored first.